169P Characteristics of clonal hematopoiesis (CH) in patients with non-small cell lung cancer (NSCLC): A retrospective analysis of plasma cell-free DNA (cfDNA) comprehensive genomic profiling

M Tagliamento,D Vasseur,A Bayle A Bayle,M Aldea,A Gazzah,C Nicotra,A Hollebecque,D Planchard,M Frelaut,A Botticella,A Levy,L Lacroix,C Marzac,J.B Micol,S Ponce,E Rouleau,A Italiano,B Besse

doi:10.1016/j.annonc.2022.02.201

169P Characteristics of clonal hematopoiesis (CH) in patients with non-small cell lung cancer (NSCLC): A retrospective analysis of plasma cell-free DNA (cfDNA) comprehensive genomic profiling

M Tagliamento, D Vasseur + Show 16 more

Open Access

https://doi.org/10.1016/j.annonc.2022.02.201

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Apr 1, 2022
License type: elsevier-specific: oa user license

Affiliation: Institut Gustave Roussy

#Clonal Hematopoiesis #Non-small Cell Lung Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

CH refers to the presence of somatic mutations charged to hematopoietic cells, potentially causing clonal expansion. We explored characteristics of CH in patients with NSCLC through liquid biopsy (LB) analysis.

Full Text